Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Tripeptidyl-peptidase II: Update on an oldie that still counts.

Tomkinson B.

Biochimie. 2019 May 17. pii: S0300-9084(19)30151-8. doi: 10.1016/j.biochi.2019.05.012. [Epub ahead of print] Review.

2.

TPP2 mutation associated with sterile brain inflammation mimicking MS.

Reinthaler EM, Graf E, Zrzavy T, Wieland T, Hotzy C, Kopecky C, Pferschy S, Schmied C, Leutmezer F, Keilani M, Lill CM, Hoffjan S, Epplen JT, Zettl UK, Hecker M, Deutschländer A, Meuth SG, Ahram M, Mustafa B, El-Khateeb M, Vilariño-Güell C, Sadovnick AD, Zimprich F, Tomkinson B, Strom T, Kristoferitsch W, Lassmann H, Zimprich A.

Neurol Genet. 2018 Nov 13;4(6):e285. doi: 10.1212/NXG.0000000000000285. eCollection 2018 Dec.

3.

ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs.

De Souza ALS, Rudin S, Chang R, Mitchell K, Crandall T, Huang S, Choi JK, Okitsu SL, Graham DL, Tomkinson B, Dellovade T.

Neurol Ther. 2018 Jun;7(1):103-128. doi: 10.1007/s40120-018-0094-z. Epub 2018 Mar 14.

4.

Tripeptidyl Peptidase II Mediates Levels of Nuclear Phosphorylated ERK1 and ERK2.

Wiemhoefer A, Stargardt A, van der Linden WA, Renner MC, van Kesteren RE, Stap J, Raspe MA, Tomkinson B, Kessels HW, Ovaa H, Overkleeft HS, Florea B, Reits EA.

Mol Cell Proteomics. 2015 Aug;14(8):2177-93. doi: 10.1074/mcp.M114.043331. Epub 2015 Jun 3.

5.

TPPII, MYBBP1A and CDK2 form a protein-protein interaction network.

Nahálková J, Tomkinson B.

Arch Biochem Biophys. 2014 Dec 15;564:128-35. doi: 10.1016/j.abb.2014.09.017. Epub 2014 Oct 7.

PMID:
25303791
6.

Characterization of the endopeptidase activity of tripeptidyl-peptidase II.

Eklund S, Dogan J, Jemth P, Kalbacher H, Tomkinson B.

Biochem Biophys Res Commun. 2012 Aug 3;424(3):503-7. doi: 10.1016/j.bbrc.2012.06.144. Epub 2012 Jul 4.

PMID:
22771804
7.

Exploring the active site of tripeptidyl-peptidase II through studies of pH dependence of reaction kinetics.

Eklund S, Lindås AC, Hamnevik E, Widersten M, Tomkinson B.

Biochim Biophys Acta. 2012 Apr;1824(4):561-70. doi: 10.1016/j.bbapap.2012.01.004. Epub 2012 Jan 14.

PMID:
22266401
8.

Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes.

Kessler JH, Khan S, Seifert U, Le Gall S, Chow KM, Paschen A, Bres-Vloemans SA, de Ru A, van Montfoort N, Franken KL, Benckhuijsen WE, Brooks JM, van Hall T, Ray K, Mulder A, Doxiadis II, van Swieten PF, Overkleeft HS, Prat A, Tomkinson B, Neefjes J, Kloetzel PM, Rodgers DW, Hersh LB, Drijfhout JW, van Veelen PA, Ossendorp F, Melief CJ.

Nat Immunol. 2011 Jan;12(1):45-53. doi: 10.1038/ni.1974. Epub 2010 Dec 12.

PMID:
21151101
9.

Development, evaluation and application of tripeptidyl-peptidase II sequence signatures.

Eriksson S, Gutiérrez OA, Bjerling P, Tomkinson B.

Arch Biochem Biophys. 2009 Apr 1;484(1):39-45. doi: 10.1016/j.abb.2009.01.007. Epub 2009 Jan 14.

PMID:
19467630
10.

Investigation of a role for Glu-331 and Glu-305 in substrate binding of tripeptidyl-peptidase II.

Lindås AC, Eriksson S, Jozsa E, Tomkinson B.

Biochim Biophys Acta. 2008 Dec;1784(12):1899-907. doi: 10.1016/j.bbapap.2008.08.017. Epub 2008 Sep 5.

PMID:
18822395
11.
12.

Overlapping regional distribution of CCK and TPPII mRNAs in Cynomolgus monkey brain and correlated levels in human cerebral cortex (BA 10).

Radu D, Tomkinson B, Zachrisson O, Weber G, de Belleroche J, Hirsch S, Lindefors N.

Brain Res. 2006 Aug 9;1104(1):175-82. Epub 2006 Jul 5.

PMID:
16822484
13.

The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine.

Clarke ML, Damaraju VL, Zhang J, Mowles D, Tackaberry T, Lang T, Smith KM, Young JD, Tomkinson B, Cass CE.

Mol Pharmacol. 2006 Jul;70(1):303-10. Epub 2006 Apr 14.

PMID:
16617163
14.

Tripeptidyl-peptidase II: a multi-purpose peptidase.

Tomkinson B, Lindås AC.

Int J Biochem Cell Biol. 2005 Oct;37(10):1933-7. Epub 2005 Mar 9. Review.

PMID:
16125107
15.

Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II.

Stavropoulou V, Xie J, Henriksson M, Tomkinson B, Imreh S, Masucci MG.

Cancer Res. 2005 Feb 15;65(4):1361-8.

16.

Identification and characterization of the promoter for the gene encoding human tripeptidyl-peptidase II.

Lindås AC, Tomkinson B.

Gene. 2005 Jan 31;345(2):249-57. Epub 2005 Jan 5.

PMID:
15716107
17.

Incorporation of OSI-7836 into DNA of Calu-6 and H460 xenograft tumors.

Richardson F, Black C, Richardson K, Franks A, Wells E, Karimi S, Sennello G, Hart K, Meyer D, Emerson D, Brown E, LeRay J, Nilsson C, Tomkinson B, Bendele R.

Cancer Chemother Pharmacol. 2005 Mar;55(3):213-21. Epub 2004 Nov 16.

PMID:
15592840
18.

Polymerization of the triphosphates of AraC, 2',2'-difluorodeoxycytidine (dFdC) and OSI-7836 (T-araC) by human DNA polymerase alpha and DNA primase.

Richardson KA, Vega TP, Richardson FC, Moore CL, Rohloff JC, Tomkinson B, Bendele RA, Kuchta RD.

Biochem Pharmacol. 2004 Dec 15;68(12):2337-46.

PMID:
15548380
19.

OSI-211, a novel liposomal topoisomerase I inhibitor, is active in SCID mouse models of human AML and ALL.

Tomkinson B, Bendele R, Giles FJ, Brown E, Gray A, Hart K, LeRay JD, Meyer D, Pelanne M, Emerson DL.

Leuk Res. 2003 Nov;27(11):1039-50.

PMID:
12859997
20.

Identification of the catalytic triad in tripeptidyl-peptidase II through site-directed mutagenesis.

Hilbi H, Jozsa E, Tomkinson B.

Biochim Biophys Acta. 2002 Dec 16;1601(2):149-54.

PMID:
12445476
21.

Tripeptidyl-peptidase II expression and activity are increased in skeletal muscle during sepsis.

Wray CJ, Tomkinson B, Robb BW, Hasselgren PO.

Biochem Biophys Res Commun. 2002 Aug 9;296(1):41-7.

PMID:
12147224
22.

Oligoclonal expansion of intraepidermal T cells in psoriasis skin lesions.

Lin WJ, Norris DA, Achziger M, Kotzin BL, Tomkinson B.

J Invest Dermatol. 2001 Dec;117(6):1546-53.

23.
24.

Biodistribution of NX211, liposomal lurtotecan, in tumor-bearing mice.

Desjardins JP, Abbott EA, Emerson DL, Tomkinson BE, Leray JD, Brown EN, Hamilton M, Dihel L, Ptaszynski M, Bendele RA, Richardson FC.

Anticancer Drugs. 2001 Mar;12(3):235-45.

PMID:
11290871
25.

Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecan.

Emerson DL, Bendele R, Brown E, Chiang S, Desjardins JP, Dihel LC, Gill SC, Hamilton M, LeRay JD, Moon-McDermott L, Moynihan K, Richardson FC, Tomkinson B, Luzzio MJ, Baccanari D.

Clin Cancer Res. 2000 Jul;6(7):2903-12.

26.
27.

Tripeptidyl peptidases: enzymes that count.

Tomkinson B.

Trends Biochem Sci. 1999 Sep;24(9):355-9. Review.

PMID:
10470035
28.

Characterization and cloning of tripeptidyl peptidase II from the fruit fly, Drosophila melanogaster.

Renn SC, Tomkinson B, Taghert PH.

J Biol Chem. 1998 Jul 24;273(30):19173-82.

30.

Distribution of tripeptidyl-peptidase II in the central nervous system of rat.

Tomkinson B, Nyberg F.

Neurochem Res. 1995 Dec;20(12):1443-7.

PMID:
8789606
31.

Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.

Robertson ES, Grossman S, Johannsen E, Miller C, Lin J, Tomkinson B, Kieff E.

J Virol. 1995 May;69(5):3108-16.

32.

Characterization of cDNA for murine tripeptidyl-peptidase II reveals alternative splicing.

Tomkinson B.

Biochem J. 1995 Mar 15;306 ( Pt 3):880. No abstract available.

34.

Use of a dehydroalanine-containing peptide as an efficient inhibitor of tripeptidyl peptidase II.

Tomkinson B, Grehn L, Fransson B, Zetterqvist O.

Arch Biochem Biophys. 1994 Nov 1;314(2):276-9.

PMID:
7979365
35.
36.

Epstein-Barr virus recombinants from overlapping cosmid fragments.

Tomkinson B, Robertson E, Yalamanchili R, Longnecker R, Kieff E.

J Virol. 1993 Dec;67(12):7298-306.

37.

Assignment of the linkage group EAM-TYRP2-TPP2 to chromosome 11 in pigs by in situ hybridization mapping of the TPP2 gene.

Chowdhary BP, Johansson M, Gu F, Bräuner-Nielsen P, Tomkinson B, Andersson L, Gustavsson I.

Chromosome Res. 1993 Sep;1(3):175-9.

PMID:
7908839
39.

Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B.

Longnecker R, Miller CL, Tomkinson B, Miao XQ, Kieff E.

J Virol. 1993 Aug;67(8):5068-74.

40.
44.
45.
46.

Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.

Swaminathan S, Tomkinson B, Kieff E.

Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1546-50.

47.
48.
49.
50.

Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.

Tomkinson BE, Maziarz R, Sullivan JL.

J Immunol. 1989 Jul 15;143(2):660-70.

PMID:
2472449

Supplemental Content

Loading ...
Support Center